chemistry, manufacturing controls (cmc) in an investigational new drug (ind) (7/14) redi 2017
Published 4 years ago • 22K plays • Length 1:20:20Download video MP4
Download video MP3
Similar videos
-
1:19:35
chemistry, manufacturing, and controls (cmc) for an ind (7of14) redi 2018
-
46:00
introduction to investigational new drug (ind) applications (3/14) redi 2017
-
27:10
overview of post-approval chemistry, manufacture, and controls (cmc) changes to an nda - redi 2020
-
2:12
chemistry, manufacturing and controls (cmc)
-
19:56
the chemistry, manufacturing and controls cmc section of a gene therapy ind
-
34:37
lifecycle changes to chemistry, manufacture, and controls in ndas - redi 2020
-
1:02:19
chemistry and manufacturing requirements for early clinical development: what’s in there? prove it.
-
20:33
ich m7(r1) – chemistry and manufacturing control (cmc) perspective on hazard assessment
-
56:31
cmc considerations for biotechnology product development: a regulatory perspective
-
37:56
regulatory and administrative components of an ind application (5/14) redi 2017
-
9:26
vol 6 - a brief guide to understanding: fda's cmc guidance for phase 2 and 3 inds
-
6:58
the critical role of cmc in your ind submission
-
5:01
chemistry manufacturing control (cmc), post approval changes- regulatory affairs
-
40:24
fda communication during drug development (4/14) redi 2017
-
40:34
demystifying the investigational new drug (ind) application for drugs and biologics (3of14) redi '18
-
18:10
sbia program overview - redi 2020
-
1:12:07
edited version - webinar about us investigational new drug (ind) applications.
-
30:07
questions and panel discussion – post-approval cmc and manufacturing - redi 2020